PET imaging of the AT1 receptor with [11C]KR31173

Nuclear Medicine and Biology

Volumn 33, Issue 1, 2006, Pages 5-13

  Zober, Tamas G ^a   Mathews, William B ^a   Seckin, Esen ^a   Yoo, Sung Eun ^b   Hilton, John ^a   Xia, Jinsong ^a   Sandberg, Kathryn ^c   Ravert, Hayden T ^a   Dannals, Robert F ^a   Szabo, Zsolt ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b Korea Research Institute of Chemical Technology   (South Korea)

^c GEORGETOWN UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Angiotensin II; Animals; AT1 receptor; Kidney; PET

Indexed keywords

1 (4 DIMETHYLAMINO 3 METHYLBENZYL) 5 DIPHENYLACETYL 4,5,6,7 TETRAHYDRO 1H IMIDAZO[4,5 C]PYRIDINE 6 CARBOXYLIC ACID; [2 BUTYL 5 METHOXYMETHYL 6 (1 OXOPYRIDIN 2 YL) 3 [[2 (1H TETRAZOL 5 YL)BIPHENYL 4 YL]METHYL] 3H IMIDAZO[4,5 B]PYRIDINE]; ANGIOTENSIN 1 RECEPTOR; ANGIOTENSIN 1 RECEPTOR ANTAGONIST; CARBON 11; KR 31173; L 159884; PYRIDINE DERIVATIVE; SK 1080; UNCLASSIFIED DRUG; 2 BUTYL 5 METHOXYMETHYL 6 (1 OXOPYRIDIN 2 YL) 3 ((2' (1H TETRAZOL 5 YL)BIPOHENYL 4 YL)METHYL) 3H IMIDAZO(4,5 B)PYRIDINE; 2-BUTYL-5-METHOXYMETHYL-6-(1-OXOPYRIDIN-2-YL)-3-((2'-(1H-TETRAZOL-5-YL)BIPOHENYL-4-YL)METHYL)-3H-IMIDAZO(4,5-B)PYRIDINE; CARBON; DIAGNOSTIC AGENT; IMIDAZOLE DERIVATIVE; RADIOPHARMACEUTICAL AGENT; TETRAZOLE DERIVATIVE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BABOON; CONTROLLED STUDY; DOG; DRUG DISTRIBUTION; DRUG PROTEIN BINDING; DRUG RECEPTOR BINDING; DRUG TISSUE LEVEL; EX VIVO STUDY; KIDNEY CORTEX; MALE; MOUSE; NONHUMAN; ORGAN DISTRIBUTION; POSITRON EMISSION TOMOGRAPHY; TISSUE DISTRIBUTION; ANIMAL; ANTIBODY SPECIFICITY; COMPARATIVE STUDY; FEASIBILITY STUDY; KIDNEY; METABOLIC CLEARANCE RATE; METABOLISM; METHODOLOGY; PAPIO; SCINTISCANNING;

ANIMALS; CARBON RADIOISOTOPES; DOGS; FEASIBILITY STUDIES; IMIDAZOLES; KIDNEY; MALE; METABOLIC CLEARANCE RATE; MICE; ORGAN SPECIFICITY; PAPIO; POSITRON-EMISSION TOMOGRAPHY; RADIOPHARMACEUTICALS; RECEPTOR, ANGIOTENSIN, TYPE 1; TETRAZOLES; TISSUE DISTRIBUTION;

EID: 31844433321     PISSN: 09698051     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.nucmedbio.2005.08.005     Document Type: Article

References (34)

1. S. Kim, and H. Iwao Molecular and cellular mechanisms of angiotensin II-mediated cardiovascular and renal diseases Pharmacol Rev 52 2000 11 34
2. T.L. Goodfriend Angiotensin receptors: history and mysteries Am J Hypertens 13 2000 442 449
3. 1 receptor imaging Appl Radiat Isot 47 1996 211 218
4. S.E. Kim, U. Scheffel, Z. Szabo, H.D. Burns, R.E. Gibson, and H.T. Ravert In vivo labeling of angiotensin II receptors with a carbon-11-labeled selective nonpeptide antagonist J Nucl Med 37 1996 307 311
5. 1 antagonist J Nucl Med 39 1998 1209 1213
6. 1 receptor regulation in vivo J Am Soc Nephrol 12 2001 1350 1358
7. 1 receptor expression by PET J Nucl Med 45 2003 94 100
8. 1 angiotensin receptor with PET Nucl Med Biol 31 2004 571 574
9. 1 receptor antagonist Fund Clin Pharmacol 12 1998 64 69
10. 18F-FDG, the ATLAS small animal PET scanner, and arterial blood sampling J Nucl Med 45 2004 665 672
11. R. Yao, J. Seidel, C.A. Johnson, M.E. Daube-Witherspoon, M.V. Green, and R.E. Carson Performance characteristics of the 3-D OSEM algorithm in the reconstruction of small animal PET images. Ordered-subsets expectation- maximization IEEE Trans Med Imaging 19 2000 798 804
12. J. Hilton, F. Yokoi, R.F. Dannals, H.T. Ravert, Z. Szabo, and D.F. Wong Column-switching HPLC for the analysis of plasma in PET imaging studies Nucl Med Biol 27 2000 627 630
13. M. Khurana, J.K. Paliwal, V.P. Kamboj, and R.C. Gupta Binding of centchroman with human serum as determined by charcoal adsorption method Int J Pharm 192 1999 109 114
14. J.H. Yuan, D.C. Yang, J. Birkmeier, and J. Stolzenbach Determination of protein-binding by in-vitro charcoal adsorption J Pharmacokinet Biopharm 23 1995 41 55
15. 11C-methyl]-(-)-cocaine PET studies in human subjects J Cereb Blood Flow Metab 10 1990 740 747
16. Z. Szabo, H. Vosberg, C.A. Sondhaus, and L.E. Feinendegen Model identification and estimation of organ-function parameters using radioactive tracers and the impulse-response function Eur J Nucl Med 11 1985 265 274
17. A. Gjedde, D.F. Wong, and H.N. Wagner Transient analysis of irreversible and reversible tracer binding in human brain L. Battistin F. Gerstenbrand PET and NMR. New perspectives in neuroimaging and in clinical neurochemistry 1985 Alan R. Liss New York 223 235
18. C.S. Patlak, R.G. Blasberg, and J.D. Fenstermacher Graphical evaluation of blood-to-brain transfer constants from multiple-time uptake data J Cereb Blood Flow Metab 3 1983 1 7
19. A. Vandekerckhove, S. Keppens, and H. De Wulf The angiotensin II receptor of rabbit liver: characterization in isolated hepatocytes and effect of GTP J Endocrinol 123 1989 131 136
20. P. Anversa, A. Leri, B. Li, Y. Liu, S. Di Somma, and J. Kajstura Ischemic cardiomyopathy and the cellular renin-angiotensin system J Heart Lung Transplant 19 2000 S1 S11
21. S. Ohtani, H. Fujiwara, K. Hasegawa, K. Doyama, T. Inada, and M. Tanaka Up-regulated expression of angiotensin II type 1 receptor gene in human pathologic hearts J Card Fail 3 1997 303 310
22. A. Gonzalez, B. Lopez, S. Ravassa, R. Querejeta, M. Larman, and J. Diez Stimulation of cardiac apoptosis in essential hypertension: potential role of angiotensin II Hypertension 39 2002 75 80
23. 18F-FHBG for quantitating herpes simplex virus type 1 thymidine kinase reporter gene expression in living animals using PET J Nucl Med 45 2004 1560 1570
24. P. Paradis, N. Dali-Youcef, F.W. Paradis, G. Thibault, and M. Nemer Overexpression of angiotensin II type I receptor in cardiomyocytes induces cardiac hypertrophy and remodeling Proc Natl Acad Sci U S A 97 2000 931 936
25. Y. Fujimoto, T. Sasaki, A. Tsuchida, and K. Chayama Angiotensin II type 1 receptor expression in human pancreatic cancer and growth inhibition by angiotensin II type 1 receptor antagonist FEBS Lett 495 2001 197 200
26. M. Maluccio, V. Sharma, M. Lagman, G. Konijn, and M. Suthanthiran Angiotensin II receptor blockade: a novel strategy to prevent immunosuppressant-associated cancer progression Transplant Proc 33 2001 1820 1821
27. 2 receptors J Inflam (Lond) 1 2004 3
28. H. Masuko, M.B. Jin, H. Horiuchi, T. Suzuki, M. Taniguchi, and T. Shimamura Protective effect of angiotensin II type I receptor antagonist, CV-11974, on ischemia and reperfusion injury of the liver Transplantation 71 2001 1034 1039
29. 1 receptor translation Endocrinology 144 2003 3251 3261
30. G. Aguilera Role of angiotensin II receptor subtypes on the regulation of aldosterone secretion in the adrenal glomerulosa zone in the rat Mol Cell Endocrinol 90 1992 53 60
31. G. Giacchetti, G. Opocher, R. Sarzani, A. Rappelli, and F. Mantero Angiotensin II and the adrenal Clin Exp Pharmacol Physiol Suppl 3 1996 S119 S124
32. R.E. McCaa Role of the renin-angiotensin system in the regulation of aldosterone biosynthesis and arterial pressure during sodium deficiency Circ Res 40 1977 I157 I162
33. A. Tanabe, M. Naruse, K. Arai, K. Naruse, T. Yoshimoto, and T. Seki Gene expression and roles of angiotensin II type 1 and type 2 receptors in human adrenals Horm Metab Res 30 1998 490 495
34. B. Schubert, M. Fassnacht, F. Beuschlein, S. Zenkert, B. Allolio, and M. Reincke Angiotensin II type 1 receptor and ACTH receptor expression in human adrenocortical neoplasms Clin Endocrinol (Oxf) 54 2001 627 632